跳至主要内容
临床试验/NCT02339714
NCT02339714已完成2 期

Effect Comparison of Acupuncture Combined With Moxibustion and Loratadine for Perennial Allergic Rhinitis: a Randomized Controlled Trial

Zhao Hong3 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2015年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
98
试验地点
3
主要终点
Change from baseline in the weekly average of the participants' total nasal symptom score (TNSS) at the 4th week.

研究概览

简要总结

A multi-centre clinical trial done by us(ISRCEN90807007)showed that active acupuncture had significantly greater effect on symptoms of allergic rhinitis than either sham acupuncture or no active treatment. The object of that study was to evaluate the effectiveness and safety of acupuncture for allergic rhinitis. As an explanatory research, acupuncture was defined as the only intervention for treatment group and sham acupuncture, no active treatment as its control groups. Besides, acupuncture combined moxibustion showed better and longer effect than acupuncture on allergic rhinitis patients in our previous pilot study. According to this result, we are taking a pragmatic randomized controlled trial to further evaluate whether acupuncture combined moxibustion is more effective than conventional treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Each participant must have a diagnosis of AR by an otolaryngology doctor, according to the criteria listed in "Allergic Rhinitis and its Impact on Asthma" (ARIA 2008) Symptoms that had persisted for more than 4 days per week for more than four consecutive weeks.
  • At least one of the following rhinitis-associated conditions: nasal obstruction, rhinorrhea, sneezing and nasal itching.
  • At least one positive result on an allergy skin prick reaction test at screening.

排除标准

  • Active tuberculosis Autoimmune disorders Severe chronic inflammatory diseases History of anaphylactic reactions Specific immunotherapy >3 years Simultaneous participation in other clinical trials Serious acute or chronic organic disease or mental disorder Congenital nasal abnormalities Pregnancy or breast feeding Blood coagulation disorder and/or current use of anticoagulants Allergy desensitisation therapy (current, during the past two years, or planned in the next two years) Previous systemically administered corticosteroids, antihistamines, or decongestants in the last 1 months prior to enrollment

研究组 & 干预措施

Acupuncture combined moxibustion

Experimental

Acupuncture at Hegu(LI4),Yingxiang(LI20),Chize(LU5),Sibai(ST2), Yintang(EX-HN3),Shangyingxiang(EX-HN8),Shangxing(GV23),Dazhui(Du14). Needle warming moxibustion at Dazhui(Du14). Patients will be treated once per day for 30 min, 3 times in a weeks for 4 weeks.

干预措施: acupuncture combined moxibustion (Other)

loratadine

Active Comparator

Loratadine taken orally, 10mg/day in the morning

干预措施: Loratadine (Drug)

结局指标

主要结局

Change from baseline in the weekly average of the participants' total nasal symptom score (TNSS) at the 4th week.

时间窗: at the 4th week

次要结局

  • Change from baseline in the weekly average of the participants' total non-nasal symptom score (TNNSS) at the 4th week(at the 4th week)
  • Change from baseline in Quality of life questionnaire (QLQ) at the 4th week(at the 4th Week)

研究者

发起方
Zhao Hong
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Zhao Hong

Vice president of acupuncture and moxibustion hospital

China Academy of Chinese Medical Sciences

研究点 (3)

Loading locations...

相似试验